Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Retinal Pigment Epithelial Atrophy in Neovascular Age-Related Macular Degeneration After Ranibizumab Treatment.

American journal of ophthalmology - 1 Jan 2016

Kuroda Yoshimasa, Yamashiro Kenji, Tsujikawa Akitaka, Ooto Sotaro, Tamura Hiroshi, Oishi Akio, Nakanishi Hideo, Miyake Masahiro, Yoshikawa Munemitsu, Yoshimura Nagahisa

Abstract excerpt

PURPOSE: To investigate the risk factors for development and progression of retinal pigment epithelial (RPE) atrophy during ranibizumab treatment for neovascular age-related macular degeneration (AMD) in Japanese patients. DESIGN: Retrospective interventional case series. METHODS: This study included 195 eyes with treatment-naïve subfoveal neovascular AMD. All patients were treated with an as-needed regimen after...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiogenesis Inhibitors
Share to Atrophy

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Complement Factor H

Share to Fluorescein Angiography

Share to Intravitreal Injections

Share to Retinal Diseases

Share to Retinal Pigment Epithelium

Share to Wet Macular Degeneration

Source

Identifiers

PMID: 26432927
DOI: 10.1016/j.ajo.2015.09.032

Genes

RPE
ARMS2
CFH

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Retinal Pigment Epithelial Atrophy in Neovascular Age-Related Macular Degeneration After Ranibizumab Treatment.PMID 26432927Read ↗

Prevalence and Genetic Characteristics of Geographic Atrophy among Elderly Japanese with Age-Related Macular DegenerationSemantic proximity Read ↗

Evaluation of clinical and genetic indicators for the early response to intravitreal ranibizumab in exudative age-related macular degeneration.Semantic proximity Read ↗

Prevalence and characteristics of age-related macular degeneration in the Japanese population: the Nagahama study.Semantic proximity Read ↗

Two-year visual outcome of ranibizumab in typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.Semantic proximity Read ↗

Incidence and progression of geographic atrophy: observations from a population-based cohort.Semantic proximity Read ↗

Consideration of patient phenotypes in geographic atrophy due to age-related macular degeneration.Semantic proximity Read ↗

Prevalence of age-related macular degeneration in elderly Caucasians: the Tromsø Eye Study.Semantic proximity Read ↗

Factors associated with the response of age-related macular degeneration to intravitreal ranibizumab treatment.Semantic proximity Read ↗

Difference between age-related macular degeneration and polypoidal choroidal vasculopathy in the hereditary contribution of the A69S variant of the age-related maculopathy susceptibility 2 gene (ARMS2).Semantic proximity Read ↗

Chorioretinal Atrophy after Voretigene Neparvovec Therapy in <italic>RPE65</italic> Mutation-Associated Inherited Retinal Disease: Longitudinal Characterization in Multimodal Imaging.Semantic proximity Read ↗

Drusen Characteristics of Type 2 Macular Neovascularization in Age-related Macular DegenerationSemantic proximity Read ↗

Geographic atrophy in Korean patients with dry age-related macular degeneration: incidence, phenotypes, and progression.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.